{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2021-04-20&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2021-04-20&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2021-04-20&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2021-04-20&_page=0&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2021-04-20&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2021-04-20&min-ddpCreated=2021-04-20T18%3A03%3A13.190Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1310647", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1310647/answer", "answerText" : {"_value" : "
We are unable to publish the Oasis application documents as had been intended as it has not been possible to produce it in an accessible format as required for all documents published on GOV.UK. A copy of the application and related documents in the form it had been intended to be published will be placed in the House library. We have made the document available on request as stated on the page providing guidance on secure schools.<\/p>
https://www.gov.uk/government/publications/secure-schools-how-to-apply<\/a><\/p> <\/p> The application submitted by Oasis in March 2019 outlined the foundation for their operating concept and proposed principles for the secure school, in line with the criteria set out in the secure schools \u2018how to apply\u2019 guide. Since they were approved as the successful applicant for the first secure school in July 2019, Oasis have continued to develop and refine their operating model. All policies submitted by Oasis were accurate for academic year 2018-19.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4481", "label" : {"_value" : "Biography information for Alex Chalk"}
}
, "answeringMemberConstituency" : {"_value" : "Cheltenham"}
, "answeringMemberPrinted" : {"_value" : "Alex Chalk"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T14:39:21.25Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "54"}
, "answeringDeptShortName" : {"_value" : "Justice"}
, "answeringDeptSortName" : {"_value" : "Justice"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Secure Schools: Medway"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Justice, when the the application submitted by Oasis Charitable Trust to run Medway Secure School will be published on the secure schools page of GOV.UK; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4786", "label" : {"_value" : "Biography information for Zarah Sultana"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Zarah Sultana"}
], "uin" : "184562"}
, {"_about" : "http://data.parliament.uk/resources/1310648", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310648/answer", "answerText" : {"_value" : " The Government is committed to the neonicotinoid restrictions put in place in 2018 and to the sustainable use of pesticides. Specific requirements for granting an emergency authorisation are laid out in pesticide regulations. In assessing whether the requirements are met, the decision maker considers the benefit of granting an emergency authorisation against an assessment of the potential harm from the proposed use of the product, taking into account the proposed conditions. This specific exemption refers to a non-flowering plant, grown in the East of England only, and we took advice on this from the Health and Safety Executive (HSE), the Expert Committee on Pesticides and our own Chief Scientific Adviser.<\/p> The HSE advised that many aspects of the environmental risk assessment met the requirements for standard authorisation. The Government concluded that the remaining risks identified could be mitigated to an acceptably low level and that, with the strict conditions of use in place, these were outweighed by the substantial benefits to crop production from the use of Cruiser SB if 2021 were to be a year of high pest pressure. One of the conditions attached was to ensure that the product would only be used if the pest pressure was predicted to pass a certain threshold. Ultimately, this threshold for usage was not met and so the neonicotinoid was not used on sugar beet crops.<\/p> The reasons for the decision to issue this emergency authorisation for the product Cruiser SB were set out more fully in the Statement on the decision to issue - with strict conditions - emergency authorisation to use a product containing a neonicotinoid to treat sugar beet seed in 2021 - GOV.UK (www.gov.uk)<\/a>.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4401", "label" : {"_value" : "Biography information for Victoria Prentis"}
}
, "answeringMemberConstituency" : {"_value" : "Banbury"}
, "answeringMemberPrinted" : {"_value" : "Victoria Prentis"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T15:32:59.463Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Neonicotinoids"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, for what reason an emergency authorisation for the use of neonicotinoids on sugar beet was approved when the Health and Safety Executive recommended in their advice to the Government that that request for use be refused.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "184478"}
, {"_about" : "http://data.parliament.uk/resources/1310649", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310649/answer", "answerText" : {"_value" : " As set out in the Integrated Review, the UK will continue to play a leading international role in multilateral governance and use our diplomacy at the UN to defend universal human rights and promote women's economic empowerment. As such our priorities at the Human Rights Council are to continue to hold states that violate human rights to account, to promote girls' education and work to end violence against women and girls, defend freedom of religion or belief, support democratic values, and protect media freedom.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4057", "label" : {"_value" : "Biography information for Nigel Adams"}
}
, "answeringMemberConstituency" : {"_value" : "Selby and Ainsty"}
, "answeringMemberPrinted" : {"_value" : "Nigel Adams"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T15:48:41.57Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "UN Human Rights Council"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what the UK Government's priorities are at the UN Human Rights Council over the next six months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"}
}
, "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"}
, "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"}
], "uin" : "184458"}
, {"_about" : "http://data.parliament.uk/resources/1310650", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310650/answer", "answerText" : {"_value" : " The total spend on centrally commissioned health and disease related research by the Foreign, Commonwealth & Development Office over the last five financial years is as follows:<\/p> 2016/17 - £84.65 million<\/p> 2017/18 - £122.08 million<\/p> 2018/19 - £132.33 million<\/p> 2019/20 - £155.41 million<\/p> 2020/21 - Final and audited spend for 2020/21 will be published in our annual report later this year.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T14:05:01.65Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Diseases and Health: Research"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what the total spending of his Department was on health and disease related research in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4264", "label" : {"_value" : "Biography information for Stephen Doughty"}
}
, "tablingMemberConstituency" : {"_value" : "Cardiff South and Penarth"}
, "tablingMemberPrinted" : [{"_value" : "Stephen Doughty"}
], "uin" : "184459"}
, {"_about" : "http://data.parliament.uk/resources/1310651", "AnsweringBody" : [{"_value" : "Ministry of Defence"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310651/answer", "answerText" : {"_value" : " The position of this, and previous Governments, is that there is no published peer-reviewed evidence of excess illness or mortality among Nuclear Test Veterans (NTVs) as a group that could be linked to participation in the tests or to exposure to radiation as a result of that participation. Formal and well-documented procedures were in place to ensure the health and safety of those participating in the testing programme.<\/p> <\/p> In response to health concerns of some NTVs in the 1980s, the Ministry of Defence (MOD) commissioned epidemiological studies into the mortality and cancer incidence among nuclear test participants. These were conducted by the independent National Radiological Protection Board (NRPB), now part of Public Health England (PHE). Three analyses were carried out, of which the latest report published in 2003 concluded that overall levels of mortality and cancer incidence in NTVs have continued to be similar to those in a matched Service control group and lower than in the general population. That report is available from the following link:<\/p> https://www.gov.uk/government/publications/mortality-and-cancer-incidence-1952-1998-uk-nuclear-weapons-tests<\/a><\/p> <\/p> To provide further reassurance, the MOD commissioned a fourth study in the NRPB series in order to bring the evidence completely up to date. The study was carried out by PHE and commenced in December 2018. The study will extend the analysis by a further almost 20 years, again considering overall mortality and cancer incidence and mortality, and comparing veterans present at the tests with a control group of age matched veterans serving at the same time, but who were not NTVs, and with the UK general population. The Department's understanding is that the study has been completed and the researchers are preparing a paper for submission to a mainstream scientific/medical journal. This will then be peer reviewed. Further details about the study are available at the following link:<\/p> <\/p> https://www.gov.uk/government/publications/nuclear-weapons-test-participants-study/plan-for-the-fourth-analysis-of-the-nuclear-weapons-test-participants-study<\/a><\/p> <\/p> Analysis of the international published peer-reviewed evidence to date provides no support for increased rates of congenital defects in children born to parents at risk of exposure to ionising radiation.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4600", "label" : {"_value" : "Biography information for Leo Docherty"}
}
, "answeringMemberConstituency" : {"_value" : "Aldershot"}
, "answeringMemberPrinted" : {"_value" : "Leo Docherty"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "184480"}
, {"_value" : "184481"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T10:51:06.117Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "11"}
, "answeringDeptShortName" : {"_value" : "Defence"}
, "answeringDeptSortName" : {"_value" : "Defence"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Veterans: Radiation Exposure"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Defence, with reference to correspondence (ref D/Min(Lords)/AGMC2021/01429e) between the Rt Hon Baroness Goldie DL and the hon Member for Salford and Eccles, what research studies have been reviewed by or on behalf of his Department demonstrating that the health and well-being of British Nuclear Test Programme 1952 -1991 Veterans is comparable with the age and sex matched population of both their Service peers and the general community.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4396", "label" : {"_value" : "Biography information for Rebecca Long Bailey"}
}
, "tablingMemberConstituency" : {"_value" : "Salford and Eccles"}
, "tablingMemberPrinted" : [{"_value" : "Rebecca Long Bailey"}
], "uin" : "184479"}
, {"_about" : "http://data.parliament.uk/resources/1310652", "AnsweringBody" : [{"_value" : "Ministry of Defence"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310652/answer", "answerText" : {"_value" : " The position of this, and previous Governments, is that there is no published peer-reviewed evidence of excess illness or mortality among Nuclear Test Veterans (NTVs) as a group that could be linked to participation in the tests or to exposure to radiation as a result of that participation. Formal and well-documented procedures were in place to ensure the health and safety of those participating in the testing programme.<\/p> <\/p> In response to health concerns of some NTVs in the 1980s, the Ministry of Defence (MOD) commissioned epidemiological studies into the mortality and cancer incidence among nuclear test participants. These were conducted by the independent National Radiological Protection Board (NRPB), now part of Public Health England (PHE). Three analyses were carried out, of which the latest report published in 2003 concluded that overall levels of mortality and cancer incidence in NTVs have continued to be similar to those in a matched Service control group and lower than in the general population. That report is available from the following link:<\/p> https://www.gov.uk/government/publications/mortality-and-cancer-incidence-1952-1998-uk-nuclear-weapons-tests<\/a><\/p> <\/p> To provide further reassurance, the MOD commissioned a fourth study in the NRPB series in order to bring the evidence completely up to date. The study was carried out by PHE and commenced in December 2018. The study will extend the analysis by a further almost 20 years, again considering overall mortality and cancer incidence and mortality, and comparing veterans present at the tests with a control group of age matched veterans serving at the same time, but who were not NTVs, and with the UK general population. The Department's understanding is that the study has been completed and the researchers are preparing a paper for submission to a mainstream scientific/medical journal. This will then be peer reviewed. Further details about the study are available at the following link:<\/p> <\/p> https://www.gov.uk/government/publications/nuclear-weapons-test-participants-study/plan-for-the-fourth-analysis-of-the-nuclear-weapons-test-participants-study<\/a><\/p> <\/p> Analysis of the international published peer-reviewed evidence to date provides no support for increased rates of congenital defects in children born to parents at risk of exposure to ionising radiation.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4600", "label" : {"_value" : "Biography information for Leo Docherty"}
}
, "answeringMemberConstituency" : {"_value" : "Aldershot"}
, "answeringMemberPrinted" : {"_value" : "Leo Docherty"}
, "dateOfAnswer" : {"_value" : "2021-04-26", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "184479"}
, {"_value" : "184481"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-26T10:51:06.177Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "11"}
, "answeringDeptShortName" : {"_value" : "Defence"}
, "answeringDeptSortName" : {"_value" : "Defence"}
, "date" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Veterans: Radiation Exposure"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Defence, when the results will be published of the fourth follow up study carried out by the National Radiological Protection Board (Public Health England) considering overall mortality and cancer incidence in Nuclear Testing Veterans, comparing veterans present at the tests with a control group of age matched veterans serving at the same time but who were not nuclear test veterans, and with the UK general population.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4396", "label" : {"_value" : "Biography information for Rebecca Long Bailey"}
}
, "tablingMemberConstituency" : {"_value" : "Salford and Eccles"}
, "tablingMemberPrinted" : [{"_value" : "Rebecca Long Bailey"}
], "uin" : "184480"}
, {"_about" : "http://data.parliament.uk/resources/1310653", "AnsweringBody" : [{"_value" : "Ministry of Defence"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1310653/answer", "answerText" : {"_value" : " The position of this, and previous Governments, is that there is no published peer-reviewed evidence of excess illness or mortality among Nuclear Test Veterans (NTVs) as a group that could be linked to participation in the tests or to exposure to radiation as a result of that participation. Formal and well-documented procedures were in place to ensure the health and safety of those participating in the testing programme.<\/p> <\/p> In response to health concerns of some NTVs in the 1980s, the Ministry of Defence (MOD) commissioned epidemiological studies into the mortality and cancer incidence among nuclear test participants. These were conducted by the independent National Radiological Protection Board (NRPB), now part of Public Health England (PHE). Three analyses were carried out, of which the latest report published in 2003 concluded that overall levels of mortality and cancer incidence in NTVs have continued to be similar to those in a matched Service control group and lower than in the general population. That report is available from the following link:<\/p> https://www.gov.uk/government/publications/mortality-and-cancer-incidence-1952-1998-uk-nuclear-weapons-tests<\/a><\/p> <\/p> To provide further reassurance, the MOD commissioned a fourth study in the NRPB series in order to bring the evidence completely up to date. The study was carried out by PHE and commenced in December 2018. The study will extend the analysis by a further almost 20 years, again considering overall mortality and cancer incidence and mortality, and comparing veterans present at the tests with a control group of age matched veterans serving at the same time, but who were not NTVs, and with the UK general population. The Department's understanding is that the study has been completed and the researchers are preparing a paper for submission to a mainstream scientific/medical journal. This will then be peer reviewed. Further details about the study are available at the following link:<\/p> <\/p>